Home > Insider Trading > Filing (0001209191-14-062753)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1496671	Calithera Biosciences Inc.	CALA	Pharmaceutical Preparations (2834)	272366329

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1255743	J James Bochnowski	C/O Delphi Ventures 3000 Sand Hill Rd., Bldg 1, Suite 135 Menlo Park CA 94025	No	No	Yes	No
1270734	Deepika Pakianathan	C/O Delphi Ventures, 3000 Sand Hill Road, Bldg. 1, Suite 135 Menlo Park CA 94025	Yes	No	Yes	No
1270735	A Douglas Roeder	C/O Delphi Ventures 3000 Sand Hill Rd., Bldg 1, Suite 135 Menlo Park CA 94025	No	No	Yes	No
1271389	L David Douglass	C/O Delphi Ventures 3000 Sand Hill Rd., Bldg 1, Suite 135 Menlo Park CA 94025	No	No	Yes	No
1436285	Delphi Ventures Viii Lp	3000 Sand Hill Rd. Bldg 1, Suite 135 Menlo Park CA 94025	No	No	Yes	No
1451526	Delphi Bioinvestments Viii Lp	3000 Sand Hill Rd. Bldg 1, Suite 135 Menlo Park CA 94025	No	No	Yes	No
1457494	Delphi Management Partners Viii, L.l.c.	C/O Delphi Ventures, 3000 Sand Hill Road, Bldg. 1, Suite 135 Menlo Park CA 94025	No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2014-10-07	1,908,073	$0.00	1,908,073	No	4	C	Indirect	Delphi Ventures VIII, L.P.
Common Stock	Acquisiton	2014-10-07	18,629	$0.00	18,629	No	4	C	Indirect	Delphi BioInvestments VIII, L.P.
Common Stock	Acquisiton	2014-10-07	495,165	$10.00	2,403,238	No	4	P	Indirect	Delphi Ventures VIII, L.P.
Common Stock	Acquisiton	2014-10-07	4,835	$10.00	23,464	No	4	P	Indirect	Delphi BioInvestments VIII, L.P.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	Delphi Ventures VIII, L.P.
No	4	C	Indirect	Delphi BioInvestments VIII, L.P.
No	4	P	Indirect	Delphi Ventures VIII, L.P.
No	4	P	Indirect	Delphi BioInvestments VIII, L.P.

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A Preferred Stock	Acquisiton	2014-10-07	6,808	$0.00	6,808	$0.00
Common Stock	Series A Preferred Stock	Acquisiton	2014-10-07	66	$0.00	66	$0.00
Common Stock	Series B Preferred Stock	Acquisiton	2014-10-07	415,128	$0.00	415,128	$0.00
Common Stock	Series B Preferred Stock	Acquisiton	2014-10-07	4,053	$0.00	4,053	$0.00
Common Stock	Series C Preferred Stock	Acquisiton	2014-10-07	740,312	$0.00	740,312	$0.00
Common Stock	Series C Preferred Stock	Acquisiton	2014-10-07	7,228	$0.00	7,228	$0.00
Common Stock	Series D Preferred Stock	Acquisiton	2014-10-07	745,825	$0.00	745,825	$0.00
Common Stock	Series D Preferred Stock	Acquisiton	2014-10-07	7,282	$0.00	7,282	$0.00

Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect

Footnotes

The preferred stock automatically converted into Common Stock on a one-for-one basis immediately upon the consummation of Issuer's initial public offering of Common Stock and had no expiration date.
The reported securities are directly owned by Delphi Ventures VIII, L.P. ("DV VIII"). Delphi Management Partners VIII, L.L.C. ("DMP VIII") is the general partner of DV VIII and may be deemed to have sole voting and dispositive power over the securities held by DV VIII. Douglas A. Roeder, James J. Bochnowski, David L. Douglass and Deepika R. Pakianathan, Ph.D. are the managing members of DMP VIII and may be deemed to share voting and dispositive power over the securities held by DV VIII. Such persons and entities disclaim beneficial ownership of the securities held by DV VIII, except to the extent of any pecuniary interest therein.
The reported securities are directly owned by Delphi BioInvestments VIII, L.P. ("DBI VIII"). DMP VIII is the general partner of DBI VIII and may be deemed to have sole voting and dispositive power over the securities held by DBI VIII. Douglas A. Roeder, James J. Bochnowski, David L. Douglass and Deepika R. Pakianathan, Ph.D. are the managing members of DMP VIII and may be deemed to share voting and dispositive power over the securities held by DBI VIII. Such persons and entities disclaim beneficial ownership of the securities held by DBI VIII, except to the extent of any pecuniary interest therein.